Triparna Sen, Professor in the Department of Internal Medicine, Associate Director of Research, and Director of the Lung Cancer Preclinical Therapeutic Platform at The Ohio State University, shared a post on X:
“I am honored and thrilled to share that, starting August 1, I have joined The Ohio State University as a Professor in the Department of Internal Medicine, Associate Director of Research, and Director of the Lung Cancer Preclinical Therapeutic Platform in the Division of Medical Oncology.
The transition to this leadership role is both humbling and exciting. I will lead efforts to advance translational research across all solid tumors, with a mission to bridge preclinical discovery and clinical impact.
I am excited to begin the next chapter of the Sen Lab here at The Ohio State University Wexner Medical Center, where my lab will continue to focus on resistance mechanisms, lineage plasticity, and therapeutic innovation in aggressive thoracic cancers. I look forward to building a strong, collaborative lung cancer research program.
I am deeply grateful to my mentors and colleagues at Icahn School of Medicine at Mount Sinai who have shaped my journey, and I look forward to working with the exceptional community at Ohio State Medical Oncology as we push the boundaries of cancer research together.”
More posts featuring Triparna Sen on OncoDaily.